home / stock / crmd / crmd news


CRMD News and Press, CorMedix Inc. From 07/17/19

Stock Information

Company Name: CorMedix Inc.
Stock Symbol: CRMD
Market: NYSE
Website: cormedix.com

Menu

CRMD CRMD Quote CRMD Short CRMD News CRMD Articles CRMD Message Board
Get CRMD Alerts

News, Short Squeeze, Breakout and More Instantly...

CRMD - CorMedix Presents at FDA Public Meeting on the Limited Population Pathway for Antibacterial and Antifungal Drugs

BERKELEY HEIGHTS, N.J., July 17, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease,  announced today that Dr. P...

CRMD - CorMedix down 3% premarket on Neutrolin NDA update

Citing FDA feedback, CorMedix (NYSEMKT: CRMD ) says it does not believe that it will be required to conduct another Phase 3 study evaluating Neutrolin as a catheter lock solution for the prevention of catheter-related bloodstream infections in hemodialysis patients. More news on: CorMedi...

CRMD - CorMedix Receives Encouraging FDA Feedback on Neutrolin® LOCK-IT-100 Data

BERKELEY HEIGHTS, N.J., July 09, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that it has rece...

CRMD - CorMedix Announces Publication of Taurolidine Pre-Clinical Oncology Data in "Investigational New Drugs" Journal

BERKELEY HEIGHTS, N.J., July 08, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced publication of ...

CRMD - New 2019 Abnormal Return Portfolio For The Russell Index Rebalancing Anomaly

Introduction Every year the Russell Indexes are rebalanced to bring in new stocks and remove underperforming stocks. The FTSE Russell calls this event the annual reconstitution process, and it begins with evaluations in May and moves to the selection process on June 7th with the newly recons...

CRMD - CorMedix Inc. Set to Join the Russell 2000® Index

BERKELEY HEIGHTS, N.J., June 26, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that it is set t...

CRMD - CorMedix Inc. to Ring NYSE Closing Bell on Monday, June 10

BERKELEY HEIGHTS, N.J., June 10, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that members of ...

CRMD - Forensic Value Selections For June: Long-Term Positive Picks Beating Negative By +18.78%

Introduction to the Positive/Negative Forensic Value Stock Selections This quantitative study continues a series of multi-year test of the top three forensic algorithms used to detect bankruptcy risk, earnings manipulation, and financial irregularities. My forward testing compiles portfolio ...

CRMD - CorMedix Inc. to Present at the 20th Annual B. Riley FBR Institutional Investor Conference

BERKELEY HEIGHTS, N.J., May 16, 2019 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory disease, today announced that management w...

CRMD - CorMedix, Inc. (CRMD) CEO Khoso Baluch on Q1 2019 Results - Earnings Call Transcript

CorMedix, Inc. (CRMD) Q1 2019 Results Earnings Conference Call May 13, 2019, 04:30 PM ET Company Participants Dan Ferry - IR-LifeSci Advisors Khoso Baluch - CEO Bob Cook - CFO Phoebe Mounts - EVP and General Counsel Paul Chew - Chief Medical Officer Conference Call Partic...

Previous 10 Next 10